FDA Investigator Frank Flores
Frank Flores has conducted inspections on 36 sites in 6 countries as of 16 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
36
Last Inspection Date:
16 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada,
Puerto Rico,
United States of America,
Nicaragua,
El Salvador,
Uruguay
FDA Investigators that have inspected at least one site in common with Frank Flores:
Aaron F Coleman,
Alphonso A Haupt, III,
Amanda M Osteen,
Anabel Veiga,
Andrew Saunders,
Ann B Borromeo,
Anna E Fain,
Carl A Huffman, III,
Cherie T Parker,
Cheryl G Scott,
Christopher T Smith,
Clara E Santiago,
Clendening,
Dana D Carter, SR DDS,
Daniel L Aisen,
David T Glover,
David Williams,
Dirk L Lincoln,
Douglas A Campbell,
Edwin J Gorney,
Emily E Smith,
Eva I Merced Medina,
Fabian Nchaparro Rodriguez,
Frances L Dejesus,
Hector Vallellanes,
Hristu B Chepa,
Jacquelyn Bradford,
Jason D Tenney,
John E Russell, Jr,
Jorge L Lajara,
Jose F Pedro,
Karl D Hezel,
Konsuela Y Glass,
Krista W Whitten,
Laiza V Garcia,
Lawrence A Butler,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Leslie A Cartmill,
Libia M Lugo,
Lisa A Warner,
Lourdes Andujar,
Marcus L Head,
Maria A Ruttell,
Markeesa M Scales,
Marshall H Kinsey,
Mary M Finn,
Marybeth Willis,
Medina,
Melanie L Drayton,
Michael C Lombardi,
Miguel A Martinez Perez,
Miguel Gmanzano Maldonado,
Moraima Jramos Valle,
Natasha N Mccants,
Pablo Feliciano,
Raymond A Lyn, Jr,
Ricardo Reyes Deleon,
Robert D Ogan,
Robert J Altobelli,
Sandy L Atkins,
Scott A Watson,
Shirhonda D Thorn,
Stacey L Witherwax,
Stephen G Mclane,
Theresa L Stewart,
Thomas B Smith,
Thomas O Morgan,
Thomas R Stanley,
Travis E Chapman,
Yazmith Guzman,
Zachary J Conlin
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more